100 related articles for article (PubMed ID: 7831943)
1. [Perspectives in gene therapy in rheumatic and degenerative diseases of the spine and joints].
Evans CH; Wehling P; Reinecke J
Z Orthop Ihre Grenzgeb; 1994; 132(6):449-52. PubMed ID: 7831943
[TBL] [Abstract][Full Text] [Related]
2. Novel gene therapy for rheumatoid arthritis by FADD gene transfer: induction of apoptosis of rheumatoid synoviocytes but not chondrocytes.
Kobayashi T; Okamoto K; Kobata T; Hasunuma T; Kato T; Hamada H; Nishioka K
Gene Ther; 2000 Mar; 7(6):527-33. PubMed ID: 10757027
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy in rheumatic diseases.
Vervoordeldonk MJ; Tak PP
Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):771-88. PubMed ID: 11812021
[TBL] [Abstract][Full Text] [Related]
4. Suppression of arthritic bone destruction by adenovirus-mediated dominant-negative Ras gene transfer to synoviocytes and osteoclasts.
Yamamoto A; Fukuda A; Seto H; Miyazaki T; Kadono Y; Sawada Y; Nakamura I; Katagiri H; Asano T; Tanaka Y; Oda H; Nakamura K; Tanaka S
Arthritis Rheum; 2003 Sep; 48(9):2682-92. PubMed ID: 13130489
[TBL] [Abstract][Full Text] [Related]
5. Intra-articular adenoviral-mediated gene transfer of trail induces apoptosis of arthritic rabbit synovium.
Yao Q; Wang S; Gambotto A; Glorioso JC; Evans CH; Robbins PD; Ghivizzani SC; Oligino TJ
Gene Ther; 2003 Jun; 10(12):1055-60. PubMed ID: 12776164
[TBL] [Abstract][Full Text] [Related]
6. PhiC31 integrase mediates integration in cultured synovial cells and enhances gene expression in rabbit joints.
Keravala A; Portlock JL; Nash JA; Vitrant DG; Robbins PD; Calos MP
J Gene Med; 2006 Aug; 8(8):1008-17. PubMed ID: 16779871
[TBL] [Abstract][Full Text] [Related]
7. Expression of basic fibroblast growth factor in synovial tissue from patients with rheumatoid arthritis and degenerative joint disease.
Qu Z; Huang XN; Ahmadi P; Andresevic J; Planck SR; Hart CE; Rosenbaum JT
Lab Invest; 1995 Sep; 73(3):339-46. PubMed ID: 7564266
[TBL] [Abstract][Full Text] [Related]
8. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
Paleolog EM; Young S; Stark AC; McCloskey RV; Feldmann M; Maini RN
Arthritis Rheum; 1998 Jul; 41(7):1258-65. PubMed ID: 9663484
[TBL] [Abstract][Full Text] [Related]
9. Suppression of intra-articular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium.
Hung GL; Galea-Lauri J; Mueller GM; Georgescu HI; Larkin LA; Suchanek MK; Tindal MH; Robbins PD; Evans CH
Gene Ther; 1994 Jan; 1(1):64-9. PubMed ID: 7584062
[TBL] [Abstract][Full Text] [Related]
10. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
[TBL] [Abstract][Full Text] [Related]
11. The SCID mouse model: novel therapeutic targets - lessons from gene transfer.
Pierer M; Müller-Ladner U; Pap T; Neidhart M; Gay RE; Gay S
Springer Semin Immunopathol; 2003 Aug; 25(1):65-78. PubMed ID: 12904892
[TBL] [Abstract][Full Text] [Related]
12. Constitutive intra-articular expression of human IL-1 beta following gene transfer to rabbit synovium produces all major pathologies of human rheumatoid arthritis.
Ghivizzani SC; Kang R; Georgescu HI; Lechman ER; Jaffurs D; Engle JM; Watkins SC; Tindal MH; Suchanek MK; McKenzie LR; Evans CH; Robbins PD
J Immunol; 1997 Oct; 159(7):3604-12. PubMed ID: 9317160
[TBL] [Abstract][Full Text] [Related]
13. Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective.
Müller-Ladner U; Roberts CR; Franklin BN; Gay RE; Robbins PD; Evans CH; Gay S
J Immunol; 1997 Apr; 158(7):3492-8. PubMed ID: 9120311
[TBL] [Abstract][Full Text] [Related]
14. Suppression of early experimental osteoarthritis by gene transfer of interleukin-1 receptor antagonist and interleukin-10.
Zhang X; Mao Z; Yu C
J Orthop Res; 2004 Jul; 22(4):742-50. PubMed ID: 15183429
[TBL] [Abstract][Full Text] [Related]
15. Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy.
Adriaansen J; Tas SW; Klarenbeek PL; Bakker AC; Apparailly F; Firestein GS; Jorgensen C; Vervoordeldonk MJ; Tak PP
Ann Rheum Dis; 2005 Dec; 64(12):1677-84. PubMed ID: 15878906
[TBL] [Abstract][Full Text] [Related]
16. Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis.
Terzioglu E; Bisgin A; Sanlioglu AD; Ulker M; Yazisiz V; Tuzuner S; Sanlioglu S
Rheumatology (Oxford); 2007 May; 46(5):783-9. PubMed ID: 17309888
[TBL] [Abstract][Full Text] [Related]
17. [Gene therapy in rheumatoid arthritis: new aspects].
Pundt N; Peters MA; Wunrau C; Pap T
Dtsch Med Wochenschr; 2008 Aug; 133(34-35):1737-41. PubMed ID: 18696407
[TBL] [Abstract][Full Text] [Related]
18. Distinctive gene expression signatures in rheumatoid arthritis synovial tissue fibroblast cells: correlates with disease activity.
Galligan CL; Baig E; Bykerk V; Keystone EC; Fish EN
Genes Immun; 2007 Sep; 8(6):480-91. PubMed ID: 17568789
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-4 adenoviral gene therapy reduces production of inflammatory cytokines and prostaglandin E2 by rheumatoid arthritis synovium ex vivo.
Woods JM; Tokuhira M; Berry JC; Katschke KJ; Kurata H; Damergis JA; Arai K; Koch AE
J Investig Med; 1999 Jul; 47(6):285-92. PubMed ID: 10431483
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: innovative vectors and therapeutic genes.
Adriaansen J; Vervoordeldonk MJ; Tak PP
Rheumatology (Oxford); 2006 Jun; 45(6):656-68. PubMed ID: 16510530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
